News

AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’
Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. In an interview with Fortune on July 6, Colin Murdoch, Isomorphic Labs ...
Google DeepMind has grand ambitions to ‘cure all diseases’ with AI. Now, it’s gearing up for its first human trials
One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to address that disease,” Colin Murdoch, Isomorphic Labs president and Google DeepMind's chief business officer said.
Google-backed Isomorphic Labs to launch human trials for AI-designed drugs
Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.
Google’s Secret Moonshot Project Gears Up For Human Trail Of AI-Designed Drugs
Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The hitherto lesser-known Google subsidiary aims to revolutionize drug development by using advanced AI to create medicines more quickly, affordably, and accurately than traditional methods.
Google Ready To Start Human Trials Of Its AI-Designed Drugs
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
Google DeepMind to soon begin human trials of AI-designed drugs
Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a significant leap in pharmaceutical innovation.
Indiatimes2d
Google DeepMind ready to start human trials of AI-designed drugs; company exec says, ‘We’re getting very close’ - Times of India
Google DeepMind's drug discovery arm, Isomorphic Labs, is almost ready to begin human trials of its AI-designed drugs.In an interview with Fortune, Colin Murdoch, President of Isomorphic Labs ...
Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'The Next Big Milestone Is…'
Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...
NBC New York3mon
Inside Isomorphic Labs, the secretive AI life sciences startup spun off ...
As DeepMind's chief business officer, Murdoch was tasked with finding business applications for DeepMind's innovations in AI research. With Isomorphic, Murdoch wanted to zero in on the ...
AOL3d
Google DeepMind has grand ambitions to ‘cure all diseases’ with AI. Now, it’s gearing up for its first human trials - AOL
Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is ...
NBC Washington3mon
Inside Isomorphic Labs, the secretive AI life sciences startup spun off from Google DeepMind - NBC4 Washington
On a rare sunny day in London at the Google DeepMind office, Colin Murdoch saw the bank deposit from his employer come through. It wasn't his paycheck. Google was investing in his startup. The ...
NBC Los Angeles3mon
Inside Isomorphic Labs, the secretive AI life sciences startup spun off from Google DeepMind - NBC Los Angeles
On a rare sunny day in London at the Google DeepMind office, Colin Murdoch saw the bank deposit from his employer come through. It wasn't his paycheck. Google was investing in his startup. Get ...